Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

A Combined 25 Mg Solid-State NMR and Ab Initio DFT Approach to Probe the Local Structural Differences in Magnesium Acetate Phases Mg(CH3 COO)2  ⋅ nH2 O (n=0, 1, 4).

Seymour VR, Day SP, Scholz G, Scheurell K, Iuga D, Griffin JM, Kemnitz E, Hanna JV, Smith ME.

Chemphyschem. 2018 Jul 17;19(14):1722-1732. doi: 10.1002/cphc.201800317. Epub 2018 May 8.

PMID:
29667743
2.

Revisiting oversight and regulation of molecular-based laboratory-developed tests: a position statement of the Association for Molecular Pathology.

Ferreira-Gonzalez A, Emmadi R, Day SP, Klees RF, Leib JR, Lyon E, Nowak JA, Pratt VM, Williams MS, Klein RD.

J Mol Diagn. 2014 Jan;16(1):3-6. doi: 10.1016/j.jmoldx.2013.10.003.

3.

Models for incomplete nucleophilic attack on a protonated carbonyl group and electron-deficient alkenes: salts and zwitterions from 1-dimethylamino-naphthalene-8-carbaldehyde.

Lari A, Pitak MB, Coles SJ, Rees GJ, Day SP, Smith ME, Hanna JV, Wallis JD.

Org Biomol Chem. 2012 Oct 14;10(38):7763-79. doi: 10.1039/c2ob25929j.

PMID:
22910881
4.

High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test.

Gold MA, Thomas MA, Huh WK, Sarto GE, Day SP.

J Low Genit Tract Dis. 2013 Jan;17(1):51-7. doi: 10.1097/LGT.0b013e31824ddbe0.

PMID:
22885641
5.

Age-stratified performance of the Cervista HPV 16/18 genotyping test in women with ASC-US cytology.

Einstein MH, Garcia FA, Mitchell AL, Day SP.

Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1185-9. doi: 10.1158/1055-9965.EPI-11-0116. Epub 2011 Apr 28.

6.

Development and regulatory strategies for drug and diagnostic co-development.

Hinman LM, Carl KM, Spear BB, Salerno RA, Becker RL, Abbott BM, Kelly JF, Mansfield E, Katz RG, Harper C, Day SP, Pacanowski MA, Pignato W.

Pharmacogenomics. 2010 Dec;11(12):1669-75. doi: 10.2217/pgs.10.141.

PMID:
21142909
7.

Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology.

Einstein MH, Martens MG, Garcia FA, Ferris DG, Mitchell AL, Day SP, Olson MC.

Gynecol Oncol. 2010 Aug 1;118(2):116-22. doi: 10.1016/j.ygyno.2010.04.013. Epub 2010 May 21.

PMID:
20488510
8.

A comparative review of laboratory-developed tests utilizing Invader HPV analyte-specific reagents for the detection of high-risk human papillomavirus.

Stillman MJ, Day SP, Schutzbank TE.

J Clin Virol. 2009 Jul;45 Suppl 1:S73-7. doi: 10.1016/S1386-6532(09)70011-3. Review.

PMID:
19651372
9.

Analytical performance of the Investigational Use Only Cervista HPV HR test as determined by a multi-center study.

Day SP, Hudson A, Mast A, Sander T, Curtis M, Olson S, Chehak L, Quigley N, Ledford J, Yen-Lieberman B, Kohn D, Quigley DI, Olson M.

J Clin Virol. 2009 Jul;45 Suppl 1:S63-72. doi: 10.1016/S1386-6532(09)70010-1.

PMID:
19651371
10.

Perioperative genomic profiles using structure-specific oligonucleotide probes.

Hogan KJ, Burmester JK, Caldwell MD, Hogan QH, Coursin DB, Green DN, Selzer RM, Broderick TP, Rusy DA, Poroli M, Lutz AL, Sanders AM, Oldenburg MC, Koelbl JA, de Arruda-Indig M, Halsey JL, Day SP, Domanico MJ.

Clin Med Res. 2009 Sep;7(3):69-84. doi: 10.3121/cmr.2009.837. Epub 2009 May 27.

11.

Detection and differentiation of wild-type and vaccine mutant varicella-zoster viruses using an Invader Plus method.

Tang YW, Allawi HT, DeLeon-Carnes M, Li H, Day SP, Schmid D.

J Clin Virol. 2007 Oct;40(2):129-34. Epub 2007 Aug 28.

PMID:
17728179
12.

Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemia.

Caslake MJ, Stewart G, Day SP, Daly E, McTaggart F, Chapman MJ, Durrington P, Laggner P, Mackness M, Pears J, Packard CJ.

Atherosclerosis. 2003 Dec;171(2):245-53.

PMID:
14644393
13.

Remodeling of cerebrospinal fluid lipoprotein particles after human traumatic brain injury.

Kay AD, Day SP, Kerr M, Nicoll JA, Packard CJ, Caslake MJ.

J Neurotrauma. 2003 Aug;20(8):717-23.

PMID:
12965051
14.

Remodelling of cerebrospinal fluid lipoproteins after subarachnoid hemorrhage.

Kay AD, Day SP, Nicoll JA, Packard CJ, Caslake MJ.

Atherosclerosis. 2003 Sep;170(1):141-6.

PMID:
12957692
15.

Erythrocyte-containing versus crystalloid cardioplegia in the rat: effects on myocardial capillaries.

Chaudhry MA, Belcher PR, Day SP, Muriithi EW, Wheatley DJ.

Ann Thorac Surg. 2003 Mar;75(3):890-8.

PMID:
12645713
16.

Lipolysis generates platelet dysfunction after in vivo heparin administration.

Muriithi EW, Belcher PR, Day SP, Chaudhry MA, Caslake MJ, Wheatley DJ.

Clin Sci (Lond). 2002 Oct;103(4):433-40.

PMID:
12241544
17.

Regulation of small dense LDL concentration in Korean and Scottish men and women.

Cho HK, Shin G, Ryu SK, Jang Y, Day SP, Stewart G, Packard CJ, Shepherd J, Caslake MJ.

Atherosclerosis. 2002 Sep;164(1):187-93.

PMID:
12119209
18.
19.

Quantitative detection of platelet aggregates in whole blood without fixation.

Muriithi EW, Belcher PR, Menys VC, Chaudhry MA, Raco L, Day SP, Wheatley DJ.

Platelets. 2000 Feb;11(1):33-7.

PMID:
10938879
20.

Heparin-induced platelet dysfunction and cardiopulmonary bypass.

Muriithi EW, Belcher PR, Day SP, Menys VC, Wheatley DJ.

Ann Thorac Surg. 2000 Jun;69(6):1827-32.

PMID:
10892931
21.

Role of genotypic analysis of the thymidine kinase gene of herpes simplex virus for determination of neurovirulence and resistance to acyclovir.

Lee NY, Tang Y, Espy MJ, Kolbert CP, Rys PN, Mitchell PS, Day SP, Henry SL, Persing DH, Smith TF.

J Clin Microbiol. 1999 Oct;37(10):3171-4. Erratum in: J Clin Microbiol 2000 Mar;38(3):1311.

22.

Diethylcarbamazine-related antimicrobial activity in Mycobacterium tuberculosis-infected blood.

Kitchen LW, Weston CM, Day SP.

J Antimicrob Chemother. 1998 Aug;42(2):241-3.

PMID:
9738843
23.

Enterotoxigenic Escherichia coli detected in foods by PCR and an enzyme-linked oligonucleotide probe.

Deng MY, Cliver DO, Day SP, Fratamico PM.

Int J Food Microbiol. 1996 Jul;30(3):217-29.

PMID:
8854176
24.

Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection.

Lovrich SD, Callister SM, DuChateau BK, Lim LC, Winfrey J, Day SP, Schell RF.

Infect Immun. 1995 Jun;63(6):2113-9.

25.
26.

Detection of hepatitis A virus in environmental samples by antigen-capture PCR.

Deng MY, Day SP, Cliver DO.

Appl Environ Microbiol. 1994 Jun;60(6):1927-33.

27.

Analysis of hepatitis A virus translation in a T7 polymerase-expressing cell line.

Whetter LE, Day SP, Brown EA, Elroy-Stein O, Lemon SM.

Arch Virol Suppl. 1994;9:291-8.

PMID:
8032260
28.

Continuous-time temporal back-propagation with adaptable time delays.

Day SP, Davenport MR.

IEEE Trans Neural Netw. 1993;4(2):348-54.

PMID:
18267734
29.

Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test.

Callister SM, Schell RF, Case KL, Lovrich SD, Day SP.

J Infect Dis. 1993 Jan;167(1):158-64.

PMID:
8418162
30.
31.

Immunoglobulin G2 confers protection against Borrelia burgdorferi infection in LSH hamsters.

Schmitz JL, Schell RF, Callister SM, Lovrich SD, Day SP, Coe JE.

Infect Immun. 1992 Jul;60(7):2677-82.

32.
33.

Supplemental Content

Support Center